Skip to main content

Articles

Page 3 of 17

  1. Central retinal artery occlusion (CRAO) is a common cause of blindness and visual morbidity. In the majority of cases, it is related to thrombotic embolism. Nevertheless, the role of inherited or acquired thro...

    Authors: Radosław Dziedzic, Lech Zaręba, Teresa Iwaniec, Agnieszka Kubicka-Trząska, Bożena Romanowska-Dixon, Stanisława Bazan-Socha and Jerzy Dropiński
    Citation: Thrombosis Journal 2023 21:81
  2. Because severe acute respiratory syndrome coronarivus 2 (SARS-CoV-2) leads to severe conditions and thrombus formation, evaluation of the coagulation markers is important in determining the prognosis and pheno...

    Authors: Emily Corneo, Rafael Garbelotto, Gabriele Prestes, Carolina Saibro Girardi, Lucas Santos, Jose Claudio Fonseca Moreira, Daniel Pens Gelain, Glauco A. Westphal, Emil Kupek, Roger Walz, Cristiane Ritter and Felipe Dal-Pizzol
    Citation: Thrombosis Journal 2023 21:80
  3. Antiplatelet drugs, such as Aspirin and Clopidogrel (Plavix) are effective in the primary prevention of thromboembolic events. They are commonly used to reduce the risk of recurrence of thromboembolism. The bo...

    Authors: Mohammad Parsa-kondelaji and Hassan Mansouritorghabeh
    Citation: Thrombosis Journal 2023 21:79
  4. Cortical vein thrombosis (CVT) is a rare form of cerebral venous sinus thrombosis (CVST) in adolescent patients that has received little attention. We aimed to analyze the clinical and radiological features of...

    Authors: Lu Liu, Chenxia Zhou, Huimin Jiang, Huimin Wei, Yifan Zhou, Yan Wu, Kaiyuan Zhang, Chuanhui Li, Jiangang Duan, Ran Meng, Chen Zhou and Xunming Ji
    Citation: Thrombosis Journal 2023 21:78
  5. Intracoronary (IC) administration of glycoprotein IIb/IIIa inhibitors (GPIs) has been studied as an adjunctive therapy to improve outcomes in patients with ST-segment elevation myocardial infarction (STEMI) un...

    Authors: JongSung Hahn, Jinyoung Jeon, Min Jung Geum, Hyun Woo Lee, Jaekyu Shin, Woo-Young Chung, Yun Mi Yu and Young-Mi Ah
    Citation: Thrombosis Journal 2023 21:76
  6. Contemporary data regarding the clinical characteristics and prognosis of left ventricular thrombus (LVT) in older adults (aged ≥ 65 years old) are lacking. In this study, we characterized elderly patients wit...

    Authors: Qian Zhang, Zhongfan Zhang, Haikuo Zheng, Chengbing Wang, Miao Yu, Daoyuan Si and Wenqi Zhang
    Citation: Thrombosis Journal 2023 21:75
  7. With its low morbidity and high mortality rates, thrombotic thrombocytopenic purpura (TTP) has imposed a critical physical and economic burden on both society and individuals. Thrombocytopenia commonly occurs ...

    Authors: Yingwei Ou, Yifan Xu, Zhaowang Tan, Lingxiao Pang, Shengqin Li, Qian Li, Wenwei Cai, Yong Nan and Jianfeng Tu
    Citation: Thrombosis Journal 2023 21:74
  8. High venous thromboembolism (VTE) rates have been described in critically ill patients with COVID-19. We hypothesized that specific clinical characteristics may help differentiate hypoxic COVID-19 patients wit...

    Authors: Jeeyune Bahk, Abdul Rehman, Kam Sing Ho, Bharat Narasimhan, Hafiza Noor Ul Ain Baloch, Jiafang Zhang, Rowena Yip, Robert Lookstein and David J Steiger
    Citation: Thrombosis Journal 2023 21:73

    The Correction to this article has been published in Thrombosis Journal 2023 21:89

  9. An accumulating body of evidence has shown that gut microbiota is involved in regulating inflammation; however, it remains undetermined if and how gut microbiota plays an important role in modulating deep veno...

    Authors: Cheng Liu, Ying Zhou, Huihui Gao, Zeping Zhang, Yu Zhou, Zifeng Xu, Chenhong Zhang, Zhen Xu, Huajun Zheng and Yan-Qing Ma
    Citation: Thrombosis Journal 2023 21:71
  10. In patients with hemophilia (PwH), bleeding often occurs in joints and muscles, and early detection of hemorrhage is important to prevent the onset and progression of mobility impairment. Complex-Image analysi...

    Authors: Ryohei Kawasaki, Asuka Sakata, Chihiro Hosoda, Suguru Harada, Tetsuhiro Soeda, Yukiko Nishida, Naoki Matsumoto, Kohei Tatsumi, Keiji Nogami, Yasushi Yoshimura and Midori Shima
    Citation: Thrombosis Journal 2023 21:70
  11. Immune thrombocytopenia (ITP), which is a well-known hemorrhagic disorder characterized by low platelet counts, has been shown to be associated with the risk of thrombosis. Thrombopoietic agents (TAs) are exte...

    Authors: Yu Dong, Zhinan Xia, Jie Zhou, Yutao Hu, Ming Yue, Yuyong Wang and Mengjiao Hu
    Citation: Thrombosis Journal 2023 21:69
  12. Right heart thrombus in transit or “free-floating right heart thrombus” is defined as thrombus(i) arising from the deep veins that embolises to the right atrium or right ventricle before reaching the pulmonary...

    Authors: Rezwan N Hussain, Amit K J Mandal, Nick Li, Jihène El Kafsi, Anastasis Sioftanos and Constantinos G Missouris
    Citation: Thrombosis Journal 2023 21:68
  13. Neutrophil extracellular traps (NETs) as special release products of neutrophils have received extensive attention. They are composed of decondensed chromatin and coated with nucleoproteins, including histones...

    Authors: Weiwei Li, Zixiang Wang, Chen’guang Su, Zheng Liao, Yinxuan Pei, Jianli Wang, Zixin Li, Shijie Fu and Jinlong Liu
    Citation: Thrombosis Journal 2023 21:67
  14. Venous thromboembolism (VTE) is a leading cause of morbidity and mortality during pregnancy and the puerperium. The vast majority of VTE occurs after childbirth. China has not yet established standard risk ass...

    Authors: Hua Li, Sheng Wan, Jindan Pei, Lu Zhang, Jing Peng and Ronghua Che
    Citation: Thrombosis Journal 2023 21:66
  15. Bleeding and thrombotic complications are the leading causes of death in acute leukemia patients. The Conventional International Society of Thrombosis and Haemostasis Disseminated Intravascular Coagulation (IS...

    Authors: Weerapat Owattanapanich, Tarinee Rungjirajittranon, Apichaya Jantataeme, Smith Kungwankiattichai and Theera Ruchutrakool
    Citation: Thrombosis Journal 2023 21:65
  16. The incidence of incidental pulmonary embolism (IPE) has greatly increased, but its clinical characteristics and outcomes are still controversial. This study aimed to compare the clinical characteristics and o...

    Authors: Yanfei Wang, Zhongfen Liu, Qiuyu Li, Lina Xia, Yunyi Wang, Danfeng Jiang, Xiaoyan Chen, Yanqun Zheng, Wei Liu, Dan Wang and Dong Xue
    Citation: Thrombosis Journal 2023 21:64
  17. The Khorana score (KS) has not been well studied in East Asian cancer patients, who have different genetic backgrounds for inherited thrombophilia, body metabolism, and cancer epidemiology.

    Authors: Hyerim Ha, Yeh-Hee Ko, Kwangsoo Kim, Junshik Hong, Gyeong-Won Lee, Seong Hyun Jeong, Soo-Mee Bang and Sung-Soo Yoon
    Citation: Thrombosis Journal 2023 21:63
  18. Neonatal portal vein thrombosis (PVT) is currently more commonly encountered as a result of advances in diagnostic tools and increase in invasive interventions.

    Authors: Huseyin Avni Solgun, Ezgi Paslı Uysalol, Cengiz Bayram, Özlem Terzi, Merih Çetinkaya, Şeyma Memur and Ali Aycicek
    Citation: Thrombosis Journal 2023 21:62
  19. Cancer-associated thrombosis is a frequent complication of cancer; however, little evidence is available regarding the association between cancer history and coronary artery stent thrombosis (ST). We aimed to ...

    Authors: Tomoyo Hamana, Hiromasa Otake, Shoichi Kuramitsu, Tomohiro Shinozaki, Masanobu Ohya, Kazunori Horie, Hiroyoshi Kawamoto, Futoshi Yamanaka, Masahiro Natsuaki, Hiroki Shiomi, Gaku Nakazawa, Kenji Ando, Kazushige Kadota, Shigeru Saito and Takeshi Kimura
    Citation: Thrombosis Journal 2023 21:60
  20. Venous thromboembolism (VTE) prophylaxis is effective in reducing VTE events, however, its impact on mortality is unclear. We examined the association between omission of VTE prophylaxis within the first 24 h ...

    Authors: Berhe W. Sahle, David Pilcher, Karlheinz Peter, James D. McFadyen, Edward Litton and Tracey Bucknall
    Citation: Thrombosis Journal 2023 21:59
  21. The assessment of hemostasis is necessary to make suitable decisions on the management of patients with thrombotic disorders. In some clinical situations, for example, during thrombophilia screening, the prese...

    Authors: Aleksandra Frackiewicz, Bartlomiej Kalaska, Joanna Miklosz and Andrzej Mogielnicki
    Citation: Thrombosis Journal 2023 21:58
  22. Gynecological cancer is one of the highest risk factors for cancer-associated thrombosis (CAT). Although low-molecular-weight heparin (LMWH) is recommended as an anticoagulant for treating CAT, recent studies ...

    Authors: Tadashi Oride, Kenjiro Sawada, Aasa Shimizu, Yasuto Kinose, Tsuyoshi Takiuchi, Michiko Kodama, Kae Hashimoto, Eiji Kobayashi, Eiji Nakatani and Tadashi Kimura
    Citation: Thrombosis Journal 2023 21:57
  23. Postoperative lung cancer patients belong to the high-risk group for venous thromboembolism (VTE). The standardized preventive measures for perioperative VTE in lung cancer are not perfect, especially for the ...

    Authors: Jingyao Li, Aihong Huang, Zhaojie Han, Yi Zhou, Meng Tang, Wei Wu, Shixin Zhang, Kelong Liao, Yihui Xie, Qiao Chen, Xinliang Zou, Shuai Liu, Shuaixiang Gao, Junlong Ren, Qingyuan Xu, Xi Liu…
    Citation: Thrombosis Journal 2023 21:56
  24. Deep vein thrombosis (DVT) is a common complication in cancer. Although thromboprophylaxis in cancer patients is recommended by the guidelines, clinicians’ use of thromboprophylaxis remains limited due to cost...

    Authors: Budi Setiawan, Widi Budianto, Tri Wahyu Sukarnowati, Daniel Rizky, Eko Adhi Pangarsa, Damai Santosa, Aru Wisaksono Sudoyo, Tri Indah Winarni, Ignatius Riwanto, Rahajuningsih Dharma Setiabudy and Catharina Suharti
    Citation: Thrombosis Journal 2023 21:54
  25. Pulmonary embolism (PE) is an important complication of Coronavirus disease 2019 (COVID-19). COVID-19 is associated with respiratory impairment and a pro-coagulative state, rendering PE more likely and difficu...

    Authors: Jakob Vielhauer, Christopher Benesch, Anna Pernpruner, Anna-Lena Johlke, Johannes Christian Hellmuth, Maximilian Muenchhoff, Clemens Scherer, Nicola Fink, Bastian Sabel, Christian Schulz, Julia Mayerle, Ujjwal Mukund Mahajan and Hans Christian Stubbe
    Citation: Thrombosis Journal 2023 21:51
  26. It remains unknown whether anticoagulation for persistent left ventricular (LV) thrombus should be continued indefinitely. Identifying patients with a high risk of thrombus unresolved may be helpful to determi...

    Authors: Qing Yang, Xin Quan, Chuangshi Wang, Litian Yu, Yanmin Yang, Jun Zhu and Yan Liang
    Citation: Thrombosis Journal 2023 21:50
  27. There is room for improvement of prevention of venous thromboembolism (VTE) after lower-leg cast application or knee arthroscopy. Information about the mechanism of clot formation in these patients may be usef...

    Authors: Carolina E. Touw, Banne Nemeth, Raymond A. van Adrichem, Astrid van Hylckama Vlieg, Rob G. H. H. Nelissen, Ton Lisman and Suzanne C. Cannegieter
    Citation: Thrombosis Journal 2023 21:49
  28. The first case of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) was reported in the letter-to-editor submission in the journal of Indian Journal of Hematology and Blood Transfusion which was published onl...

    Authors: Jyoti Kotwal and K. V. Vinu Balraam
    Citation: Thrombosis Journal 2023 21:47

    The original article was published in Thrombosis Journal 2022 20:11

    The Response to this article has been published in Thrombosis Journal 2023 21:48

  29. There are very few documented reports in literature of cerebral venous sinus thrombosis (CVST) caused by immune-mediated heparin-induced thrombocytopenia (HIT). Further, there are very few reports of false neg...

    Authors: Floyd D. Silva, Allison E. Burnett, Anand Padmanabhan, Marian A. Rollins-Raval, Noah P. Splinter and Masoom J. Desai
    Citation: Thrombosis Journal 2023 21:46
  30. Patients with venous anomalies are at increased risk of developing venous thromboembolism (VTE) and subsequent complications, but they are often under-recognised. While unprovoked VTE may trigger testing for i...

    Authors: Caroline Dix, Warren Clements, Harry Gibbs, Joanne So, Huyen A Tran and James D McFadyen
    Citation: Thrombosis Journal 2023 21:45
  31. Atypical hemolytic uremic syndrome (aHUS) is caused by complement dysregulation and is generally diagnosed by exclusion from other disorders of thrombotic microangiopathy (TMA). Eculizumab, a terminal compleme...

    Authors: Hideo Wada, Hirofumi Teranishi, Akihiko Shimono, Noritoshi Kato, Shoichi Maruyama and Masanori Matsumoto
    Citation: Thrombosis Journal 2023 21:43
  32. Patients with critical illness due to COVID-19 exhibit increased coagulability associated with a high risk of venous thrombo-embolism (VTE). Data on prophylactic anticoagulation for these patients are limited ...

    Authors: Pauline Lamouche-Wilquin, Léa Perrin, Morgane Pere, Matthieu Raymond, Pierre Asfar, Cedric Darreau, Florian Reizine, Gwenhaël Colin, Agathe Delbove, Johann Auchabie, Baptiste Hourmant, Aurélien Frérou, Béatrice La Combe, Jean Morin, Pierre Kergoat, Julien Lorber…
    Citation: Thrombosis Journal 2023 21:42
  33. Blood transfusion and previous stroke history are two independent risk factors of venous thromboembolism (VTE) in stroke patients. Whether the potential interaction of transfusion history and previous stroke h...

    Authors: Changqing Sun, Rongrong Wang, Lianke Wang, Panpan Wang, Ying Qin, Qianyu Zhou, Yuanli Guo, Mingyang Zhao, Wenqian He, Bo Hu, Zihui Yao, Peijia Zhang, Tiantian Wu, Yu Wang and Qiang Zhang
    Citation: Thrombosis Journal 2023 21:41
  34. Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke w...

    Authors: Lulu Sun, Daoxia Guo, Yiming Jia, Mengyao Shi, Pinni Yang, Yu Wang, Fanghua Liu, Zhengbao Zhu and Jin Zheng
    Citation: Thrombosis Journal 2023 21:40
  35. Acute mesenteric ischemia (AMI) is a life-threatening condition with a high mortality rate. The standard practice after making the diagnosis includes aggressive resuscitation, anticoagulation, followed by reva...

    Authors: Yuqian Tian, Sanjeev Dhara, Christopher D. Barrett, Aaron P. Richman and Tejal S. Brahmbhatt
    Citation: Thrombosis Journal 2023 21:39
  36. Post-thrombotic syndrome (PTS) is a complication of deep vein thrombosis (DVT) and affects 20–40% of DVT subjects. The risk factor of PTS after DVT is difficult to determine. We aimed to evaluate the incidence...

    Authors: Farieda Ariyanti, Lugyanti Sukrisman, Dono Antono and Kuntjoro Harimurti
    Citation: Thrombosis Journal 2023 21:38
  37. Based on the few available studies on the prognostic benefit of using direct oral anticoagulants (DOACs) after atrial fibrillation (AF) ablation. Therefore, this study aimed to evaluate the prognostic differen...

    Authors: Shuyi Wu, Chengfu Guan, Wenlin Xu, Feilong Zhang, Nianxu Huang, Xia Chen, Wang Zhang, Wei Hu, Jun Su, Hengfen Dai, Ping Gu, Xiaohong Huang, Xiaoming Du, Ruijuan Li, Qiaowei Zheng, Xiangsheng Lin…
    Citation: Thrombosis Journal 2023 21:37
  38. Microwave ablation (MWA) via ultrasound guidance is an important tool in the treatment of liver metastases. The most common postoperative complications are abdominal hemorrhage and bile leakage, whereas thromb...

    Authors: Jun Ma, Juan Zhu, Tengyun Ding, Libin Cai, Chaoping Zhou and Yaming Zhang
    Citation: Thrombosis Journal 2023 21:36
  39. Liver disease is any condition that affects the liver cells and their function. It is directly linked to coagulation disorders since most coagulation factors are produced by the liver. Therefore, this study ai...

    Authors: Abateneh Melkamu, Berhanu Woldu, Chomaw Sitotaw, Masresha Seyoum and Melak Aynalem
    Citation: Thrombosis Journal 2023 21:35
  40. The present study aimed to investigate the prevalence, predictors, and management of left atrial appendage (LAA) thrombogenic milieu (TM) identified with transesophageal echocardiography (TEE) in non-valvular ...

    Authors: Yu Qiao, Zhen Zhao, Xiang Cai, Yulong Guo, Ke Liu, Jinrui Guo, Tao Guo and Guodong Niu
    Citation: Thrombosis Journal 2023 21:34
  41. Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare malignancy-related respiratory complication, demonstrating rapid progression of pulmonary hypertension (PH) and respiratory failure. Although a numbe...

    Authors: Yang Wang, Wei-wei Ning, Yi-fan Jin, Qing-qing Zhu, Zai-liang Wang, Nan Su, Yan-bin Chen, Jian-an Huang and Cheng Chen
    Citation: Thrombosis Journal 2023 21:33
  42. Current guidelines recommend extending the use of dual antiplatelet therapy (DAPT) beyond 1 year in patients with an acute coronary syndrome (ACS) and a high risk of ischaemia and low risk of bleeding. No data...

    Authors: Albert Ariza-Solé, Gemma Mateus-Porta, Francesc Formiga, Sergio Garcia-Blas, Clara Bonanad, Iván Núñez-Gil, Carlos Vergara-Uzcategui, Pablo Díez-Villanueva, Jordi Bañeras, Clara Badia-Molins, Jaime Aboal, José Carreras-Mora, Ana Gabaldón-Pérez, José Antonio Parada-Barcia, Manuel Martínez-Sellés, Josep Comín-Colet…
    Citation: Thrombosis Journal 2023 21:32

Official journal of

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.011 - SNIP (Source Normalized Impact per Paper)
    0.699 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    107 days submission to accept (Median)

    2023 Usage 
    708,004 downloads
    943 Altmetric mentions